位置:首页 > 蛋白库 > STAT_HUMAN
STAT_HUMAN
ID   STAT_HUMAN              Reviewed;          62 AA.
AC   P02808; A6NKE9; B2R4F8;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1989, sequence version 2.
DT   03-AUG-2022, entry version 172.
DE   RecName: Full=Statherin;
DE   Flags: Precursor;
GN   Name=STATH;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=3502720;
RA   Sabatinai L., Carlock L., Johnson G., Azen E.;
RT   "cDNA cloning and chromosomal localization (4q11-13) of a gene for
RT   statherin, a regulator of calcium in saliva.";
RL   Am. J. Hum. Genet. 41:1048-1060(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=3426601; DOI=10.1016/0006-291x(87)90436-0;
RA   Dickinson D.P., Ridall A.L., Levine M.J.;
RT   "Human submandibular gland statherin and basic histidine-rich peptide are
RT   encoded by highly abundant mRNA's derived from a common ancestral
RT   sequence.";
RL   Biochem. Biophys. Res. Commun. 149:784-790(1987).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2373369; DOI=10.1016/0378-1119(90)90012-g;
RA   Sabatini L.M., He Y.-Z., Azen E.A.;
RT   "Structure and sequence determination of the gene encoding human salivary
RT   statherin.";
RL   Gene 89:245-251(1990).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Thyroid;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PROTEIN SEQUENCE OF 20-62 (ISOFORM 1), AND PHOSPHORYLATION AT SER-21 AND
RP   SER-22.
RX   PubMed=838735; DOI=10.1016/s0021-9258(17)40603-x;
RA   Schlesinger D.H., Hay D.I.;
RT   "Complete covalent structure of statherin, a tyrosine-rich acidic peptide
RT   which inhibits calcium phosphate precipitation from human parotid saliva.";
RL   J. Biol. Chem. 252:1689-1695(1977).
RN   [9]
RP   PROTEIN SEQUENCE OF 20-62 (ISOFORMS 1 AND 2), VARIANT PHE-62 DEL, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=1663737; DOI=10.1016/0003-9969(91)90147-m;
RA   Jensen J.L., Lamkin M.S., Troxler R.F., Oppenheim F.G.;
RT   "Multiple forms of statherin in human salivary secretions.";
RL   Arch. Oral Biol. 36:529-534(1991).
RN   [10]
RP   PARTIAL PROTEIN SEQUENCE OF 1-16.
RX   PubMed=3476566; DOI=10.1177/00220345870660021301;
RA   Oppenheim F.G., Hay D.I., Smith D.J., Offner G.D., Troxler R.F.;
RT   "Molecular basis of salivary proline-rich protein and peptide synthesis:
RT   cell-free translations and processing of human and macaque statherin mRNAs
RT   and partial amino acid sequence of their signal peptides.";
RL   J. Dent. Res. 66:462-466(1987).
RN   [11]
RP   PROTEIN SEQUENCE OF 20-62 (ISOFORM 1), AND SULFATION.
RX   PubMed=17389930; DOI=10.7150/ijbs.3.237;
RA   Kasinathan C., Gandhi N., Ramaprasad P., Sundaram P., Ramasubbu N.;
RT   "Tyrosine sulfation of statherin.";
RL   Int. J. Biol. Sci. 3:237-241(2007).
RN   [12]
RP   TRANSGLUTAMINATION, AND MASS SPECTROMETRY.
RX   PubMed=17313100; DOI=10.1002/jssc.200600244;
RA   Cabras T., Inzitari R., Fanali C., Scarano E., Patamia M., Sanna M.T.,
RA   Pisano E., Giardina B., Castagnola M., Messana I.;
RT   "HPLC-MS characterization of cyclo-statherin Q-37, a specific cyclization
RT   product of human salivary statherin generated by transglutaminase 2.";
RL   J. Sep. Sci. 29:2600-2608(2006).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Salivary protein that stabilizes saliva supersaturated with
CC       calcium salts by inhibiting the precipitation of calcium phosphate
CC       salts. It also modulates hydroxyapatite crystal formation on the tooth
CC       surface.
CC   -!- INTERACTION:
CC       P02808; Q13520: AQP6; NbExp=3; IntAct=EBI-738687, EBI-13059134;
CC       P02808; Q96Q80: DERL3; NbExp=3; IntAct=EBI-738687, EBI-12831318;
CC       P02808; Q9Y282: ERGIC3; NbExp=3; IntAct=EBI-738687, EBI-781551;
CC       P02808; Q5JX71: FAM209A; NbExp=3; IntAct=EBI-738687, EBI-18304435;
CC       P02808; Q96P31-6: FCRL3; NbExp=3; IntAct=EBI-738687, EBI-17443171;
CC       P02808; Q96LL3: FIMP; NbExp=3; IntAct=EBI-738687, EBI-12887376;
CC       P02808; Q8TDT2: GPR152; NbExp=3; IntAct=EBI-738687, EBI-13345167;
CC       P02808; O15529: GPR42; NbExp=3; IntAct=EBI-738687, EBI-18076404;
CC       P02808; P48051: KCNJ6; NbExp=3; IntAct=EBI-738687, EBI-12017638;
CC       P02808; A8MZ59: LEUTX; NbExp=3; IntAct=EBI-738687, EBI-17490413;
CC       P02808; Q6N075: MFSD5; NbExp=3; IntAct=EBI-738687, EBI-3920969;
CC       P02808; Q6IN84: MRM1; NbExp=3; IntAct=EBI-738687, EBI-5454865;
CC       P02808; Q9H2K0: MTIF3; NbExp=3; IntAct=EBI-738687, EBI-3923617;
CC       P02808; Q8TAX7: MUC7; NbExp=2; IntAct=EBI-738687, EBI-738582;
CC       P02808; Q9H6H4: REEP4; NbExp=3; IntAct=EBI-738687, EBI-7545592;
CC       P02808; O95470: SGPL1; NbExp=3; IntAct=EBI-738687, EBI-1046170;
CC       P02808; Q3KNW5: SLC10A6; NbExp=3; IntAct=EBI-738687, EBI-18159983;
CC       P02808; Q9NP94: SLC39A2; NbExp=3; IntAct=EBI-738687, EBI-12898013;
CC       P02808; Q6ZMD2-2: SPNS3; NbExp=3; IntAct=EBI-738687, EBI-17848320;
CC       P02808; Q00059: TFAM; NbExp=3; IntAct=EBI-738687, EBI-1049924;
CC       P02808; Q96MV1: TLCD4; NbExp=3; IntAct=EBI-738687, EBI-12947623;
CC       P02808; Q96HE8: TMEM80; NbExp=3; IntAct=EBI-738687, EBI-11742770;
CC       P02808; Q9Y320: TMX2; NbExp=3; IntAct=EBI-738687, EBI-6447886;
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC         Comment=Both isoforms can occur with the Phe-62 deletion.;
CC       Name=1;
CC         IsoId=P02808-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P02808-2; Sequence=VSP_045744;
CC   -!- TISSUE SPECIFICITY: Secreted by parotid and submandibular glands.
CC   -!- PTM: Substrate for transglutaminase-2. More than 95% of the cyclized
CC       peptide is cyclo-statherin Q-37, and less than 5% is cyclo-statherin Q-
CC       39. Cyclized forms account for about 1% of total statherin in saliva.
CC       {ECO:0000269|PubMed:17313100}.
CC   -!- PTM: Sulfated on tyrosine residues. {ECO:0000269|PubMed:17389930}.
CC   -!- MASS SPECTROMETRY: Mass=5380.0; Mass_error=0.3; Method=Electrospray;
CC       Note=With phosphorylated Ser-21 and Ser-22.;
CC       Evidence={ECO:0000269|PubMed:17313100};
CC   -!- MASS SPECTROMETRY: Mass=5363.0; Mass_error=0.3; Method=Electrospray;
CC       Note=With phosphorylated Ser-21 and Ser-22 and transglutamine cross-
CC       link.; Evidence={ECO:0000269|PubMed:17313100};
CC   -!- SIMILARITY: Belongs to the histatin/statherin family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M18078; AAA60594.1; -; mRNA.
DR   EMBL; M18371; AAA60600.1; -; mRNA.
DR   EMBL; M32639; AAA60593.1; -; Genomic_DNA.
DR   EMBL; AK311812; BAG34755.1; -; mRNA.
DR   EMBL; AC063956; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471057; EAX05604.1; -; Genomic_DNA.
DR   EMBL; CH471057; EAX05605.1; -; Genomic_DNA.
DR   EMBL; BC067219; AAH67219.1; -; mRNA.
DR   CCDS; CCDS33998.1; -. [P02808-2]
DR   CCDS; CCDS3533.1; -. [P02808-1]
DR   PIR; JH0153; SBHUP.
DR   RefSeq; NP_001009181.1; NM_001009181.1. [P02808-2]
DR   RefSeq; NP_003145.1; NM_003154.2. [P02808-1]
DR   AlphaFoldDB; P02808; -.
DR   BioGRID; 112656; 45.
DR   IntAct; P02808; 32.
DR   MINT; P02808; -.
DR   STRING; 9606.ENSP00000246895; -.
DR   TCDB; 1.C.79.1.2; the channel-forming histatin antimicrobial peptide (histatin) family.
DR   iPTMnet; P02808; -.
DR   PhosphoSitePlus; P02808; -.
DR   BioMuta; STATH; -.
DR   EPD; P02808; -.
DR   MassIVE; P02808; -.
DR   MaxQB; P02808; -.
DR   PaxDb; P02808; -.
DR   PeptideAtlas; P02808; -.
DR   PRIDE; P02808; -.
DR   ProteomicsDB; 51602; -. [P02808-1]
DR   TopDownProteomics; P02808-1; -. [P02808-1]
DR   TopDownProteomics; P02808-2; -. [P02808-2]
DR   Antibodypedia; 44306; 68 antibodies from 16 providers.
DR   DNASU; 6779; -.
DR   Ensembl; ENST00000246895.9; ENSP00000246895.4; ENSG00000126549.11. [P02808-1]
DR   Ensembl; ENST00000381060.2; ENSP00000370448.2; ENSG00000126549.11. [P02808-2]
DR   Ensembl; ENST00000634727.1; ENSP00000489107.1; ENSG00000282891.4. [P02808-2]
DR   Ensembl; ENST00000635686.2; ENSP00000489243.1; ENSG00000282891.4. [P02808-1]
DR   Ensembl; ENST00000676772.1; ENSP00000503126.1; ENSG00000282891.4. [P02808-1]
DR   GeneID; 6779; -.
DR   KEGG; hsa:6779; -.
DR   MANE-Select; ENST00000246895.9; ENSP00000246895.4; NM_003154.3; NP_003145.1.
DR   UCSC; uc003heu.2; human. [P02808-1]
DR   CTD; 6779; -.
DR   DisGeNET; 6779; -.
DR   GeneCards; STATH; -.
DR   HGNC; HGNC:11369; STATH.
DR   HPA; ENSG00000126549; Tissue enriched (salivary).
DR   MIM; 184470; gene.
DR   neXtProt; NX_P02808; -.
DR   OpenTargets; ENSG00000126549; -.
DR   PharmGKB; PA36187; -.
DR   VEuPathDB; HostDB:ENSG00000126549; -.
DR   eggNOG; ENOG502TD50; Eukaryota.
DR   GeneTree; ENSGT00940000164572; -.
DR   HOGENOM; CLU_208169_0_0_1; -.
DR   InParanoid; P02808; -.
DR   OMA; CIQERRY; -.
DR   OrthoDB; 1640595at2759; -.
DR   PhylomeDB; P02808; -.
DR   TreeFam; TF341588; -.
DR   PathwayCommons; P02808; -.
DR   SignaLink; P02808; -.
DR   BioGRID-ORCS; 6779; 12 hits in 1055 CRISPR screens.
DR   ChiTaRS; STATH; human.
DR   GeneWiki; STATH; -.
DR   GenomeRNAi; 6779; -.
DR   Pharos; P02808; Tbio.
DR   PRO; PR:P02808; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   RNAct; P02808; protein.
DR   Bgee; ENSG00000126549; Expressed in olfactory segment of nasal mucosa and 70 other tissues.
DR   Genevisible; P02808; HS.
DR   GO; GO:0005576; C:extracellular region; NAS:UniProtKB.
DR   GO; GO:0030197; F:extracellular matrix constituent, lubricant activity; NAS:UniProtKB.
DR   GO; GO:0046848; F:hydroxyapatite binding; NAS:UniProtKB.
DR   GO; GO:0030345; F:structural constituent of tooth enamel; NAS:UniProtKB.
DR   GO; GO:0031214; P:biomineral tissue development; IEA:UniProtKB-KW.
DR   GO; GO:0042742; P:defense response to bacterium; IEA:InterPro.
DR   GO; GO:0030502; P:negative regulation of bone mineralization; NAS:UniProtKB.
DR   GO; GO:0001503; P:ossification; TAS:ProtInc.
DR   GO; GO:0046541; P:saliva secretion; NAS:UniProtKB.
DR   DisProt; DP02207; -.
DR   InterPro; IPR030773; Histatin/statherin.
DR   InterPro; IPR005575; Statherin.
DR   PANTHER; PTHR15057; PTHR15057; 1.
DR   Pfam; PF03875; Statherin; 1.
DR   PIRSF; PIRSF002565; Statherin; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Biomineralization; Direct protein sequencing;
KW   Isopeptide bond; Phosphoprotein; Reference proteome; Secreted; Signal;
KW   Sulfation.
FT   SIGNAL          1..19
FT                   /evidence="ECO:0000269|PubMed:3476566"
FT   CHAIN           20..62
FT                   /note="Statherin"
FT                   /id="PRO_0000022422"
FT   REGION          20..25
FT                   /note="Hydroxyapatite-binding; inhibits crystal growth"
FT   REGION          38..62
FT                   /note="Hydrophobic; inhibits precipitation of calcium
FT                   phosphate salts"
FT   MOD_RES         21
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:838735"
FT   MOD_RES         22
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:838735"
FT   CROSSLNK        25..58
FT                   /note="Isoglutamyl lysine isopeptide (Lys-Gln); in form
FT                   cyclo-statherin Q-39"
FT   CROSSLNK        25..56
FT                   /note="Isoglutamyl lysine isopeptide (Lys-Gln); in form
FT                   cyclo-statherin Q-37"
FT   VAR_SEQ         25..34
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_045744"
FT   VARIANT         62
FT                   /note="Missing"
FT                   /evidence="ECO:0000269|PubMed:1663737"
FT                   /id="VAR_069065"
SQ   SEQUENCE   62 AA;  7304 MW;  CFE32EC235CA3A22 CRC64;
     MKFLVFAFIL ALMVSMIGAD SSEEKFLRRI GRFGYGYGPY QPVPEQPLYP QPYQPQYQQY
     TF
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024